Prostate cancer remains a significant health concern globally, driving continuous research into novel therapeutic agents. Among the compounds showing particular promise is Elocalcitol, a synthetic analog of vitamin D. This pharmaceutical intermediate, identified by CAS 199798-84-0, is gaining attention for its potent ability to inhibit the growth and invasion of prostate cancer cells. NINGBO INNO PHARMCHEM CO.,LTD. is a key provider of such critical research chemicals.

Elocalcitol's mechanism of action is rooted in its role as a selective vitamin D receptor (VDR) agonist. The VDR is a nuclear receptor that regulates the expression of numerous genes involved in cell growth, differentiation, and apoptosis. By activating the VDR, Elocalcitol can modulate these cellular processes in cancer cells, leading to an anti-proliferative effect. Specifically, studies have shown that elocalcitol prostate cancer inhibition is achieved through its impact on key signaling pathways.

Research indicates that Elocalcitol can inhibit growth factor-stimulated proliferation and invasion in prostate cancer cell lines, such as DU145. This suggests that Elocalcitol can interfere with the processes that allow cancer cells to grow uncontrollably and spread to other parts of the body. The vitamin D receptor agonist elocalcitol mechanism is central to these observed effects.

The accessibility of Elocalcitol through reliable suppliers like NINGBO INNO PHARMCHEM CO.,LTD. is crucial for researchers investigating new cancer therapies. Understanding the detailed elocalcitol 199798-84-0 properties helps scientists to effectively utilize this compound in their studies. For those looking to source this valuable research chemical, engaging with reputable elocalcitol manufacturers suppliers is paramount.

Beyond its direct anti-proliferative effects, Elocalcitol also exhibits anti-inflammatory properties, which can be relevant in the context of cancer development and progression. Chronic inflammation is known to contribute to tumorigenesis, and compounds that can modulate inflammatory pathways may offer a dual benefit in cancer treatment strategies.

The prospect of finding new treatments for prostate cancer is ongoing, and Elocalcitol stands out as a compound with significant potential. Its ability to target cancer cell proliferation and invasion, coupled with its VDR agonist activity, makes it a compelling subject for further research and drug development. The ability to buy elocalcitol online from trusted sources facilitates this critical scientific inquiry.